Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company has posted minuscule financial performances till FY21 and has marked bumper top and bottom line for the first half of the current fiscal. Since the company is having third party trading activity, sustainability of such performance going forward is a major concern. Even with this super current earning, its asking price is at a P/E of 54 making it a costly bet. There is no harm in ignoring this pricy offer. Read detail review...
Achyut Healthcare IPO Reviews, analysis and views by popular members. Read Achyut Healthcare Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP